KERYX BIOPHARMACEUTICALS, INC. RETENTION BONUS AWARD AGREEMENTRetention Bonus Award Agreement • August 9th, 2018 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This Retention Bonus Award Agreement (this “Agreement”) is made and entered into on May 1, 2018 (the “Effective Date”), between Keryx Biopharmaceuticals, Inc. (the “Company”) and John F. Neylan, M.D. (“Employee”).
AMENDMENT NO. 1 TO PRODUCT MANUFACTURE AND SUPPLY AND FACILITY CONSTRUCTION AGREEMENTProduct Manufacture and Supply and Facility Construction Agreement • August 9th, 2018 • Keryx Biopharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 1 to the Product Manufacture and Supply and Facility Construction Agreement (“Amendment No. 1”) is made and entered into as of April 20, 2018 (the “Amendment No. 1 Effective Date”) by and between BioVectra Inc., with its registered offices at 11 Aviation Avenue, Charlottetown, PEI, C1E 0A1, Canada (“BioVectra”) and Keryx Biopharmaceuticals, Inc., with its offices at One Marina Park Drive, 12th floor, Boston, Massachusetts, 02210, USA (“Keryx”).
